Equity Incentive Plans	9 Months Ended
Sep. 30, 2024
Equity [Abstract]
Equity Incentive Plans	Equity Incentive Plans: Total compensation cost for share-based payments recognized for the three and nine months ended September 30, 2024 totaled $12,108 and $35,835, respectively, of which $1,610 and $4,424, respectively, was recorded to cost of goods sold with the remainder recorded to selling, general and administrative expense. The share-based compensation cost includes an adjustment related to the reassessment of the probability of achieving performance conditions related to certain outstanding share-based awards. Total compensation cost for share-based payments recognized for the three and nine months ended September 30, 2023 totaled $7,132 and $21,118, respectively, of which $1,621 and $4,861, respectively, was recorded to cost of goods sold with the remainder recorded to selling, general and administrative expense. During the nine months ended September 30, 2024, 0 stock options were granted and 196 stock options were exercised. During the nine months ended September 30, 2024, 117 restricted stock units were granted at a weighted average grant-date fair market value of $106.61. During the nine months ended September 30, 2024, 78 restricted stock units vested.

Equity Incentive Plans

9 Months Ended

Sep. 30, 2024

Equity Incentive Plans:

Total compensation cost for share-based payments recognized for the three and nine months ended September 30, 2024 totaled $12,108 and $35,835, respectively, of which $1,610 and $4,424, respectively, was recorded to cost of goods sold with the remainder recorded to selling, general and administrative expense. The share-based compensation cost includes an adjustment related to the reassessment of the probability of achieving performance conditions related to certain outstanding share-based awards.

Total compensation cost for share-based payments recognized for the three and nine months ended September 30, 2023 totaled $7,132 and $21,118, respectively, of which $1,621 and $4,861, respectively, was recorded to cost of goods sold with the remainder recorded to selling, general and administrative expense.

During the nine months ended September 30, 2024, 0 stock options were granted and 196 stock options were exercised.

During the nine months ended September 30, 2024, 117 restricted stock units were granted at a weighted average grant-date fair market value of $106.61. During the nine months ended September 30, 2024, 78 restricted stock units vested.